MDOI International Journal of Multidisciplinary Studies and Innovative Researchs 110.0164/INT.2026.00139
110.0164/INT.2026.00139
Article

Bilateral Adrenal Nodules in the Setting of Disseminated Fungal Infection: An Important Consideration for Appropriate Management of Adrenal Pathology

Bailey N. Johnson MD , Signe Braafladt MD , John-Paul Lavik MD, PhD , Lillian Walton BS, Alexandria D. McDow MD, FACS 2024 International Journal of Multidisciplinary Studies and Innovative Researchs

Abstract

Background/Objective Increased utilization of cross-sectional imaging has led to a rise in diagnosis of incidental adrenal lesions. Physicians in many clinical settings are increasingly faced with addressing these incidental lesions by initiating the correct workup, diagnosis, and long-term follow-up plan. Our objective was to demonstrate the importance of maintaining a broad differential and completing a thorough workup in determining the correct treatment plan for patients with bilateral adrenal lesions. Case Report We present 2 patients who recently completed chemotherapy for lymphoma, found to have new bilateral adrenal lesions on postchemotherapy imaging. Urine antigen and/or adrenal biopsy was performed to confirm the diagnosis of disseminated fungal infection. This diagnosis has major implications on the treatment plan, which includes antifungal therapy instead of surgical management or additional chemotherapy. Cross-sectional imaging after initiation of antifungal treatment demonstrated decreasing size of nodules. Discussion A broad differential is critical when working up and developing treatment plans for adrenal nodules, specifically considering a fungal etiology in the setting of immunosuppression or primary extra-adrenal malignancy. Conclusion Incidentally found adrenal lesions are becoming more common, and in turn, the obligation for appropriate management of adrenal pathology not only falls to medical and surgical endocrinologists but also to general practitioners. It is prudent to consider atypical etiologies including disseminated fungal infection prior to surgical excision or initiation of chemotherapy as those treatment strategies would not benefit select patients.

Identifier Metadata

Identifier 110.0164/INT.2026.00139
Canonical mdoi:110.0164/INT.2026.00139
Resolver URL https://mdoi.org/110.0164/INT.2026.00139
Resource URL Open resource
Document URL Open document
Content Type Article
Authors Bailey N. Johnson MD , Signe Braafladt MD , John-Paul Lavik MD, PhD , Lillian Walton BS, Alexandria D. McDow MD, FACS
Year 2024
Depositor International Journal of Multidisciplinary Studies and Innovative Researchs Organisation
Prefix 110.0164
Registered June 16, 2026
Updated June 16, 2026
Status Active
Visibility Public

Cite This Identifier

APA 7th Edition

Click to copy

MLA 9th Edition

Click to copy

Chicago 17th Edition

Click to copy

BibTeX

Click to copy

Persistent Identifier

mdoi:110.0164/INT.2026.00139

Click to copy

About MDOI

MDOI identifiers are permanent and unique identifiers assigned to digital objects to ensure long-term access, tracking, and referencing.

  • MDOI provides a permanent identity for digital objects.
  • Each MDOI is unique and points to one specific resource.
  • The prefix, such as 110.XXXX, identifies the registrant.
  • The suffix identifies the exact digital object.
  • MDOI remains stable even when a website URL changes.
  • It helps prevent broken links in digital publishing.
  • It makes academic and digital resources easier to find and cite.
  • MDOI supports proper tracking and management of digital content.
  • It improves the credibility and visibility of published resources.
  • MDOI ensures digital objects remain accessible, traceable, and reliable over time.
IN
Registered by International Journal of Multidisciplinary Studies and Innovative Researchs